A family cluster of Middle East Respiratory Syndrome Coronavirus infections related to a likely unrecognized asymptomatic or mild case - PubMed (original) (raw)

Case Reports

Ali S Omrani et al. Int J Infect Dis. 2013 Sep.

Abstract

Background: Ninety confirmed cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) have been reported to the World Health Organization. We report the details of a second family cluster of MERS-CoV infections from Riyadh, Saudi Arabia.

Methods: We present the clinical, laboratory and epidemiological details of 3 patients from a family cluster of MERS-CoV infections.

Results: The first patient developed respiratory symptoms and fever 14 days after admission to hospital for an unrelated reason. He died 11 days later with multi-organ failure. Two of his brothers presented later to another hospital with respiratory symptoms and fever. MERS-CoV infection in the latter 2 patients was confirmed by reverse transcriptase polymerase chain reaction testing. All 3 patients had fever, cough, shortness of breath, bilateral infiltrates on chest x-ray, thrombocytopenia, lymphopenia and rises in serum creatinine kinase and alanine transaminase. No hospital or other social contacts are known to have acquired the infection. It appears that the index patient in this cluster acquired MERS-CoV infection whilst in hospital from an unrecognized mild or asymptomatic case.

Conclusion: MERS-CoV acquisition from unrecognized mild or asymptomatic cases may be a more important contributor to ongoing transmission than previously appreciated.

Keywords: Cluster; MERS-CoV; Middle East Respiratory Syndrome Coronavirus; Saudi Arabia; Viral pneumonia.

Copyright © 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Chest radiograph from patient 2 with severe MERS-CoV pneumonia showing bilateral pulmonary infiltrates.

Figure 2

Figure 2

Computerized tomography scan from patient 3 with mild to moderate MERS-CoV infection showing bilateral peripheral air space consolidation.

Figure 3

Figure 3

Clinical timelines for three patients with definite or probable Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection.

Similar articles

Cited by

References

    1. Zaki A.M., van Boheemen S., Bestebroer T.M., Osterhaus A.D., Fouchier R.A. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367:1814–1820. - PubMed
    1. van Boheemen S., de Graaf M., Lauber C., Bestebroer T.M., Raj V.S., Zaki A.M. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. mBio. 2012;3 pii: e00473-12. - PMC - PubMed
    1. de Groot R.J., Baker S.C., Baric R.S., Brown C.S., Drosten C., Enjuanes L. Middle East Respiratory Syndrome Coronavirus (MERS-CoV); Announcement of the Coronavirus Study Group. J Virol. 2013;87:7790–7792. - PMC - PubMed
    1. World Health Organization. WHO guidelines for investigation of cases of human infection with Middle East Respiratory Syndrome Coronavirus (July 2013). (Accessed 12 July 2013, at http://www.who.int/csr/disease/coronavirus_infections/MERS_CoV_investiga...).
    1. Hijawi B., Abdallat M., Sayaydeh A. Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation. East Mediterr Health J. 2013;19:S12–S18. - PubMed

Publication types

MeSH terms

LinkOut - more resources